VDAC1 and Alzheimer disease: In particular, the beneficial effect produced by NHK1 peptide makes it clear how promising this approach is for the treatment of AD and other diseases in which VDAC1 is crucially involved (Shteinfer‐Kuzmine et al. 2019; Risiglione et al. 2021; Hoogerheide et al. 2017; Conti Nibali et al. 2024).